How were Flex Pharma's earnings last quarter?

Flex Pharma Inc (NASDAQ:FLKS) issued its quarterly earnings data on Wednesday, May, 1st. The biotechnology company reported ($0.12) earnings per share (EPS) for the quarter. The biotechnology company earned $0.11 million during the quarter. Flex Pharma had a negative net margin of 1,208.42% and a negative trailing twelve-month return on equity of 98.04%.

What other stocks do shareholders of Flex Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Flex Pharma investors own include Ocular Therapeutix (OCUL) , Micron Technology (MU) , Idera Pharmaceuticals (IDRA) , SCYNEXIS (SCYX) , Gilead Sciences (GILD) , Histogenics (HSGX) , TG Therapeutics (TGTX) , TherapeuticsMD (TXMD) , Celldex Therapeutics (CLDX) and Melinta Therapeutics (MLNT) .

When did Flex Pharma IPO?

Flex Pharma (FLKS) raised $60 million in an initial public offering (IPO) on Thursday, January 29th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Jefferies and Piper Jaffray acted as the underwriters for the IPO and JMP Securities, Cantor Fitzgerald and Roth Capital Partners were co-managers.

NASDAQ:FLKS

Flex Pharma (FLKS) Stock Price, News & Analysis

→ Now Open: Crypto emergency update (From InvestorPlace) (Ad)

Free FLKS Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $0.48
▼
$0.51
50-Day Range: $0.57
▼
$14.51
52-Week Range: $0.26
▼
$1.49

Volume: 8,779 shs
Average Volume: 2.03 million shs
Market Capitalization: $8.76 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Competitors Social Media

Get Flex Pharma alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Flex Pharma Stock (NASDAQ:FLKS)

Flex Pharma, Inc., a biotechnology company, develops and commercializes products for the treatment of muscle cramps, spasms, and spasticity associated with neurological conditions and exercise-associated muscle cramps in the United States. It operates in two segments, Consumer Operations and Drug Development. The company's lead drug candidate is FLX-787, a single molecule, chemically synthesized, and dual transient receptor potential V1/A1 ion channel activator, which completed an exploratory Phase II clinical trial in Australia for the treatment of patients with multiple sclerosis. It also offers HOTSHOT, a consumer beverage to prevent and treat exercise associated muscle cramps. The company markets and sells its HOTSHOT products online through its direct-to-consumer Website and through third-party Websites, including a retailer that offers international shipping. Flex Pharma, Inc. was founded in 2014 and is headquartered in Boston, Massachusetts.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

FLKS Stock News Headlines

April 4, 2024 | seekingalpha.com

Flex Ltd.: Undervalued With Solid Fundamentals

November 17, 2023 | seekingalpha.com

FLEX LNG Ltd. 2023 Q3 - Results - Earnings Call Presentation

April 19, 2024 | InvestorPlace (Ad)

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

October 30, 2023 | msn.com

Unforgettable Patients: A guy came to the ER for a scratch on his neck and "feeling drowsy." As we start the routine workups, he suddenly drops dead. Days later, his autopsy ...

September 4, 2023 | msn.com

ANGLE release Portrait Flex CTC assay

September 1, 2023 | msn.com

Why flex work is as important as pay for some

June 3, 2023 | news.yahoo.com

22-year-old woman arrested in Forks after threatening homeowner with gun

May 24, 2023 | fool.com

Flex (NASDAQ: FLEX)

April 19, 2024 | InvestorPlace (Ad)

You’re invited: Biggest crypto event of 2024

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

March 28, 2023 | wsj.com

Flex Ltd.

March 25, 2023 | forbes.com

That's All Folks: Why the Writing Is on the Wall at Microsoft

March 24, 2023 | bbc.co.uk

Folk Club with Lynette Fay

March 10, 2023 | msn.com

California flexed its muscle on abortion rights. Will more states and businesses follow?

December 12, 2022 | news.yahoo.com

Company to add new flex work space to Shelby

September 7, 2022 | finance.yahoo.com

Optimal Flex Plays: We are back baby!

August 11, 2022 | seekingalpha.com

OncoCyte Corporation (OCX) CEO Ronnie Andrews on Q2 2022 Results - Earnings Call Transcript

June 16, 2022 | seekingalpha.com

The Kraft Heinz Company's (KHC) Management Presents at Deutsche Bank Annual dbAccess Global Consumer Conference (Transcript)

June 15, 2022 | seekingalpha.com

The Kraft Heinz Company (KHC) Presents at Deutsche Bank Annual dbAccess Global Consumer Conference (Transcript)

June 8, 2022 | finance.yahoo.com

Over 500+ Weight Loss Smoothie Recipes Revealed By Cocinaré For Their New Gopower eLite Personal Portable Blender Launch

May 21, 2022 | dailymail.co.uk

Monkeypox is now spotted in Italy and Sweden — bringing number of countries with confirmed or suspected cases to SEVEN

May 20, 2022 | msn.com

My Fair Lady, The Breach and Rambert: The best of the week’s live reviews

May 16, 2022 | seekingalpha.com

Ginkgo Bioworks Holdings, Inc. (DNA) CEO Jason Kelly on Q1 2022 Results - Earnings Call Transcript

May 14, 2022 | seekingalpha.com

Zymergen, Inc. (ZY) CEO Jay Flatley on Q1 2022 Results - Earnings Call Transcript

May 5, 2022 | seekingalpha.com

Becton, Dickinson and Company (BDX) CEO Thomas Polen on Q2 2022 Results - Earnings Call Transcript

April 14, 2022 | ca.finance.yahoo.com

Toyota's first EV will start at $42,000

March 6, 2022 | yahoo.com

Biden May Extend Pause On Student Loan Payments Again: Top Aide

January 31, 2022 | msn.com

Ford F-150, Chevy Silverado, Ram 3500 Flex Some Muscle In Tug Of War

See More Headlines

Receive FLKS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Flex Pharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 5/01/2019
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical Preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:FLKS
CUSIP: N/A
CIK: 1615219
Web: www.flex-pharma.com
Phone: 617-874-1821
Fax: N/A
Employees: 4
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-21,920,000.00
Net Margins: -1,208.42%
Pretax Margin: N/A
Return on Equity: -98.04%
Return on Assets: -83.37%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 6.86
Quick Ratio: 6.74

Sales & Book Value

Annual Sales: $840,000.00
Price / Sales: 10.43
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.51 per share
Price / Book: 0.95

Miscellaneous

Outstanding Shares: 18,070,000
Free Float: N/A
Market Cap: $8.76 million
Optionable: Not Optionable
Beta: 1.65

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

Dr. William K. McVicar (Age 61)
Pres, CEO & Director
Dr. Roderick MacKinnon (Age 63)
Co-Founder & Co-Chair of Scientific Advisory Board
Mr. John McCabe (Age 49)
CFO, Treasurer & Sec.
Dr. Thomas C. Wessel (Age 63)
Outside Advisor
Dr. Bruce Bean
Co-Founder, Co-Chair of Scientific Advisory Board & Board Observer

Key Competitors

View All Competitors

FLKS Stock Analysis - Frequently Asked Questions

How were Flex Pharma's earnings last quarter?: Flex Pharma Inc (NASDAQ:FLKS) issued its quarterly earnings data on Wednesday, May, 1st. The biotechnology company reported ($0.12) earnings per share (EPS) for the quarter. The biotechnology company earned $0.11 million during the quarter. Flex Pharma had a negative net margin of 1,208.42% and a negative trailing twelve-month return on equity of 98.04%.
What other stocks do shareholders of Flex Pharma own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Flex Pharma investors own include Ocular Therapeutix (OCUL), Micron Technology (MU), Idera Pharmaceuticals (IDRA), SCYNEXIS (SCYX), Gilead Sciences (GILD), Histogenics (HSGX), TG Therapeutics (TGTX), TherapeuticsMD (TXMD), Celldex Therapeutics (CLDX) and Melinta Therapeutics (MLNT).
When did Flex Pharma IPO?: Flex Pharma (FLKS) raised $60 million in an initial public offering (IPO) on Thursday, January 29th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Jefferies and Piper Jaffray acted as the underwriters for the IPO and JMP Securities, Cantor Fitzgerald and Roth Capital Partners were co-managers.

This page (NASDAQ:FLKS) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Flex Pharma (FLKS) Stock Price, News & Analysis

About Flex Pharma Stock (NASDAQ:FLKS)

FLKS Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

FLKS Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info